dTAG-47 is a heterobifunctional compound designed to target the mutant FKBP12, which functions as a degradation tag when fused to a protein of interest. This unique structure facilitates targeted protein degradation, making it a valuable tool for investigating basal-like breast cancers. Its bifunctional nature enhances selectivity and efficacy in protein modulation studies.
Usually ships within 24 hours.